InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (60 ops.)
Discover the full record of transactions filed by MPM BioVentures 2014, L.P., Board Member / Venture Capital Investor. Officer active across 4 companies, notably Werewolf Therapeutics, Inc.. In total, 70 disclosures have been published. Total volume traded: €36.2m. The latest transaction was filed on 4 January 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations70 total
€4m94,745 shares@ €37.20519.5% of flow
Common Stock
SEC:0001209191-22-002169:0·
€4m94,745 shares@ €37.20519.5% of flow
Common Stock
SEC:0001209191-22-002168:0·
€4m94,745 shares@ €37.20538.9% of flow
Common Stock
SEC:0001209191-22-002168·
€4m94,745 shares@ €37.20538.9% of flow
Common Stock
SEC:0001209191-22-002169·
€538,90117,569 shares@ €30.67343.0% of flow
Common Stock
SEC:0001209191-21-068410:0·
€538,90117,569 shares@ €30.67346.0% of flow
Common Stock
SEC:0001209191-21-068408·
€538,90117,569 shares@ €30.67343.0% of flow
Common Stock
SEC:0001209191-21-068408:0·
€538,90117,569 shares@ €30.67346.0% of flow
Common Stock
SEC:0001209191-21-068410·
€179,6695,861 shares@ €30.6552.0% of flow
Common Stock
SEC:0001209191-21-067706·
€179,6695,861 shares@ €30.6551.0% of flow
Common Stock
SEC:0001209191-21-067707:0·
€179,6695,861 shares@ €30.6551.0% of flow
Common Stock
SEC:0001209191-21-067706:0·
€179,6695,861 shares@ €30.6552.0% of flow
Common Stock
SEC:0001209191-21-067707·
€207,2176,545 shares@ €31.66031.1% of flow
Common Stock
SEC:0001209191-21-067148:0·
€207,2176,545 shares@ €31.66032.3% of flow
Common Stock
SEC:0001209191-21-067148·
€207,2176,545 shares@ €31.66032.3% of flow
Common Stock
SEC:0001209191-21-067150·
€207,2176,545 shares@ €31.66031.1% of flow
Common Stock
SEC:0001209191-21-067150:0·
015,671 shares0
Common Stock
SEC:0001209191-21-066853·
015,671 shares0
Common Stock
SEC:0001209191-21-066853:0·
015,671 shares0
Common Stock
SEC:0001209191-21-066852:0·
015,671 shares0
Common Stock
SEC:0001209191-21-066852·
3,816,760 shares
Common Stock
SEC:0001209191-21-062983:0·
3,816,760 shares
Common Stock
SEC:0001209191-21-062982:0·
3,816,760 shares
Common Stock
SEC:0001209191-21-062983·
3,816,760 shares
Common Stock
SEC:0001209191-21-062982·
€211,2108,893 shares@ €23.75011.2% of flow
Common Stock
SEC:0001209191-21-060723:0·
25 of 70 declarations
About MPM BioVentures 2014, L.P.
MPM BioVentures 2014, L.P. is a life-sciences investment vehicle associated with the MPM Capital platform. In public-company filings, it appears as a significant stockholder and governance participant in multiple U.S.-listed biotechnology companies, including Entrada Therapeutics, Werewolf Therapeutics, and iTeos Therapeutics. Because it is a fund rather than an operating company executive, its most notable “role” is best described as institutional investor and board-affiliated shareholder, with influence exercised through ownership positions, voting agreements, and portfolio-company governance rights rather than day-to-day management. Public disclosures also show that MPM BioVentures 2014, L.P. sits within a broader MPM structure that includes managing entities and senior investment professionals who can act on its behalf in portfolio governance and strategic oversight. In that context, its track record is tied to backing emerging biopharmaceutical companies, supporting financings, and participating in the oversight of development-stage therapeutics businesses as they advance clinical and corporate milestones.
